Paul Herendeen Insider Trading
Get free email notifications about insider trading for Paul Herendeen.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Paul Herendeen. Paul Herendeen is a EVP and CFO in Valeant Pharmaceuticals International, Inc. ($BVF) and a EVP, Chief Financial Officer in Valeant Pharmaceuticals International, Inc. ($BVF) and a Exec. V.P. and CFO in Warner Chilcott plc ($WCRX) and a Exec. V.P. and CFO in Zoetis Inc. ($ZTS).
Address: WARNER CHILCOTT CORPORATION 100 ENTERPRISE DRIVE ROCKAWAY 07866 NJ
Companies in which Paul Herendeen is an Insider
Bausch Health Companies Inc.
Trading Symbol: BVFIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Herendeen: EVP and CFO, EVP, Chief Financial Officer
Holdings: 395,619 shares
Latest Transaction: Mar 10 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Warner Chilcott plc
Trading Symbol: WCRXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Herendeen: Exec. V.P. and CFO
Holdings: 893,992 shares
Latest Transaction: Jan 22 2009
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Zoetis Inc.
Trading Symbol: ZTSIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Paul Herendeen: Exec. V.P. and CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jul 20 2016
$ZTS Market Capitalization: $27.63B
$ZTS Previous Close: $55.98
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Paul Herendeen
Sentiment: All, BVF, WCRX, ZTS
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | M | 0.00 | 49,324 | 0 | 0 | |
Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 32.97 | 59,519 | 1,962,341 | 386,618 | 446.1 K to 386.6 K (-13.34 %) |
Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 50,518 | 0 | 446,137 | 395.6 K to 446.1 K (+12.77 %) |
Mar 10 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Buy | M | 0.00 | 49,324 | 0 | 395,619 | 346.3 K to 395.6 K (+14.24 %) |
Mar 05 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Option Exercise | A | 32.56 | 91,684 | 2,985,231 | 91,684 | |
Mar 05 2021 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Grant | A | 0.00 | 63,439 | 0 | 346,295 | 282.9 K to 346.3 K (+22.43 %) |
Sep 16 2020 | BVF | Bausch Health Comp ... | Herendeen Paul | EVP and CFO | Payment of Exercise | F | 15.91 | 1,642 | 26,124 | 298,611 | 300.3 K to 298.6 K (-0.55 %) |